Mark W. Begor - Feb 13, 2025 Form 4 Insider Report for EQUIFAX INC (EFX)

Role
CEO, Director
Signature
/s/Lisa Stockard as Attorney-in-Fact
Stock symbol
EFX
Transactions as of
Feb 13, 2025
Transactions value $
-$1,709,691
Form type
4
Date filed
2/18/2025, 04:14 PM
Previous filing
Feb 13, 2025
Next filing
Apr 2, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFX Common Stock Options Exercise $3.89M +22.2K +15.58% $175.48 164K Feb 13, 2025 Direct F1, F2
transaction EFX Common Stock Sale -$151K -595 -0.36% $253.60 164K Feb 13, 2025 Direct F1, F2, F3
transaction EFX Common Stock Sale -$359K -1.4K -0.86% $256.31 162K Feb 13, 2025 Direct F1, F2, F4
transaction EFX Common Stock Sale -$404K -1.6K -0.99% $252.38 161K Feb 13, 2025 Direct F1, F2, F5
transaction EFX Common Stock Sale -$1.33M -5.21K -3.24% $255.27 156K Feb 13, 2025 Direct F1, F2, F6
transaction EFX Common Stock Sale -$1.55M -6.2K -3.98% $250.74 149K Feb 13, 2025 Direct F1, F2, F7
transaction EFX Common Stock Sale -$1.8M -7.15K -4.79% $251.60 142K Feb 13, 2025 Direct F1, F2, F8
holding EFX Common Stock 43.4K Feb 13, 2025 2-Year 2023 GRAT
holding EFX Common Stock 20K Feb 13, 2025 2-year Feb 2024 GRAT
holding EFX Common Stock 24.1K Feb 13, 2025 2-yr Jul 2024 GRAT
holding EFX Common Stock 24.2K Feb 13, 2025 3-yr Jul 2024 GRAT
holding EFX Common Stock 12.3K Feb 13, 2025 4-Year 2021 GRAT

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFX Stock Option/Right to Buy Options Exercise $0 -22.2K -50% $0.00 22.2K Feb 13, 2025 Common Stock 22.2K $175.48 Direct F1, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/14/2024.
F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 147 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.
F3 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $253.26 to $254.19, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F4 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $255.89 to $256.78, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F5 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $252.24 to $252.61, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F6 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $254.815 to $255.77, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F7 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $250.095 to $251.03, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F8 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $251.17 to $252.14, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F9 The option vested in three equal annual increments beginning 2/21/2021.